Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP) | MicrobiomeTrials← Back to trialsNCT04978272
Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP)
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2022-02-08Est. Completion: 2027-05-05
Enrollment target: 924 participants Locations- IDRC - Tororo Research Clinic, Tororo, Uganda
Other microbiome trials you might be interested in
Malaria
Background:
Malaria is a disease that affects many people in Africa. It is caused by germs carried by some mosquitoes. …
Ou(SqrRoot)(Copyright)less(SqrRoot)(Copyright)bougou, MaliCompleted Nov 30, 2026
Plasmodium Vivax MalariaMalaria
FLAME is an open-label cluster-randomized controlled trial that aims to determine the effectiveness of focal mass drug a…
Iquitos, PeruEst. completion May 1, 2027